Total submissions: 20
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029791 | SCV000052445 | likely benign | Marfan syndrome | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely benign. |
Laboratory for Molecular Medicine, |
RCV000150694 | SCV000198053 | benign | not specified | 2014-08-18 | criteria provided, single submitter | clinical testing | Thr2761Thr in Exon 65 of FBN1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence and has been identified in 0.8% (35/4396) of Afri can American chromosomes from a broad population by the NHLBI Exome Sequencing P roject (http://evs.gs.washington.edu/EVS; dbSNP rs146120912). |
Gene |
RCV000150694 | SCV000233715 | benign | not specified | 2014-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000150694 | SCV000336714 | benign | not specified | 2015-11-06 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000369333 | SCV000392052 | likely benign | Acromicric dysplasia | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000315787 | SCV000392054 | likely benign | Stiff skin syndrome | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000029791 | SCV000392055 | likely benign | Marfan syndrome | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000261872 | SCV000392056 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000321804 | SCV000392057 | likely benign | Ectopia lentis 1, isolated, autosomal dominant | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000376421 | SCV000392058 | likely benign | Weill-Marchesani syndrome | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000286706 | SCV000392059 | likely benign | Geleophysic dysplasia | 2018-02-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Labcorp Genetics |
RCV000471768 | SCV000557019 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000150694 | SCV000603636 | benign | not specified | 2016-10-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000261872 | SCV000738396 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000261872 | SCV000904492 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-09-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000029791 | SCV004844904 | benign | Marfan syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001725935 | SCV005212651 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000150694 | SCV001807669 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001725935 | SCV001964797 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004532417 | SCV004752389 | benign | FBN1-related disorder | 2020-08-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |